Companies / Germany
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Drugmakers Increase Capital Investment
April 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Drugmakers operating in Germany increased their investment in plants and equipment in 2006, according to a recent survey by the research-based drug industry organisation, VFA, although the market is failing to attract new investors. The VFA claims that its members spent EUR1.5bn (US$2.03bn) upgrading facilities last year, an increase of around 20%, with the highest spend coming from Swiss drugmaker